Impact of COVID-19 on Pregnancy.

Szczegóły
Abstrakt

Tytuł:: Impact of COVID-19 on Pregnancy.
Autorzy:: Wang CL; Department of Obstetrics and Gynecology, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung, Medical University, Kaohsiung, Taiwan.; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. .
Liu YY; Department of Obstetrics and Gynecology, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung, Medical University, Kaohsiung, Taiwan.
Wu CH; Department of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung, Medical University, Kaohsiung, Taiwan.
Wang CY; Advanced mechanical engineering with management MSc, School of Engineering, University of Leicester, United Kingdom.
Wang CH; Department of Nursing, Fooyin University, Ta-Liao District, Kaohsiung, Taiwan.
Long CY; Department of Obstetrics and Gynecology, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung, Medical University, Kaohsiung, Taiwan.; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. .
Źródło:: International journal of medical sciences [Int J Med Sci] 2021 Jan 01; Vol. 18 (3), pp. 763-767. Date of Electronic Publication: 2021 Jan 01 (Print Publication: 2021).
Typ publikacji:: Journal Article; Systematic Review
Język:: English
Imprint Name(s):: Original Publication: [Australia] : Ivyspring International Publisher, c2004-
MeSH Terms:: Infectious Disease Transmission, Vertical*
Pregnancy Outcome*
COVID-19/*epidemiology
Pregnancy Complications, Infectious/*epidemiology
SARS-CoV-2/*immunology
Adult ; COVID-19/immunology ; COVID-19/therapy ; COVID-19/transmission ; Female ; Humans ; Infant, Newborn ; Maternal Exposure ; Middle East Respiratory Syndrome Coronavirus/immunology ; Pregnancy ; Pregnancy Complications, Infectious/immunology ; Pregnancy Complications, Infectious/therapy ; Pregnancy Complications, Infectious/virology ; Severe acute respiratory syndrome-related coronavirus/immunology ; SARS-CoV-2/isolation & purification ; Severe Acute Respiratory Syndrome/epidemiology ; Severe Acute Respiratory Syndrome/immunology ; Severe Acute Respiratory Syndrome/virology ; Severity of Illness Index
References:: JAMA. 2020 Apr 7;323(13):1239-1242. (PMID: 32091533)
Int J Gynaecol Obstet. 2020 Jul;150(1):47-52. (PMID: 32330287)
J Perinatol. 2020 Oct;40(10):1455-1458. (PMID: 32778684)
Int J Infect Dis. 2020 May;94:91-95. (PMID: 32173574)
Transl Pediatr. 2020 Feb;9(1):51-60. (PMID: 32154135)
Emerg Infect Dis. 2020 Jun;26(6):1335-1336. (PMID: 32134381)
Emerg Infect Dis. 2006 Nov;12(11):1638-43. (PMID: 17283611)
Lancet. 2020 Feb 22;395(10224):565-574. (PMID: 32007145)
BJOG. 2004 Aug;111(8):771-4. (PMID: 15270922)
Am J Obstet Gynecol. 2004 Jul;191(1):292-7. (PMID: 15295381)
N Engl J Med. 2020 Feb 20;382(8):727-733. (PMID: 31978945)
Am J Obstet Gynecol. 2020 Jul;223(1):111.e1-111.e14. (PMID: 32335053)
Viruses. 2020 Feb 10;12(2):. (PMID: 32050635)
N Engl J Med. 2020 Apr 30;382(18):1708-1720. (PMID: 32109013)
AJR Am J Roentgenol. 2020 Jul;215(1):127-132. (PMID: 32186894)
Am Fam Physician. 1999 Apr 1;59(7):1813-8, 1820. (PMID: 10208701)
Ultrasound Obstet Gynecol. 2020 May;55(5):593-598. (PMID: 32207208)
Lancet. 2020 Mar 7;395(10226):809-815. (PMID: 32151335)
J Microbiol Immunol Infect. 2019 Jun;52(3):501-503. (PMID: 29907538)
Semin Perinatol. 2020 Nov;44(7):151286. (PMID: 32826081)
BJOG. 2020 Oct;127(11):1324-1336. (PMID: 32531146)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
Am J Obstet Gynecol. 2020 May;222(5):415-426. (PMID: 32105680)
Acta Obstet Gynecol Scand. 2020 Jul;99(7):823-829. (PMID: 32259279)
Lancet. 2020 Feb 22;395(10224):e40. (PMID: 32035511)
Contributed Indexing:: Keywords: Coronavirus disease 2019 (COVID-19); Pregnancy; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Wuhan pneumonia
Entry Date(s):: Date Created: 20210113 Date Completed: 20210118 Latest Revision: 20221207
Update Code:: 20240105
PubMed Central ID:: PMC7797535
DOI:: 10.7150/ijms.49923
PMID:: 33437211
: Czasopismo naukowe

Full Text Finder

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is an emerging disease. There has been a rapid increase in cases and deaths since it was identified in Wuhan, China, in early December 2019, with over 4,000,000 cases of COVID-19 including at least 250,000 deaths worldwide as of May 2020. However, limited data about the clinical characteristics of pregnant women with COVID-19 have been reported. Given the maternal physiologic and immune function changes during pregnancy, pregnant women may be at a higher risk of being infected with SARS-CoV-2 and developing more complicated clinical events. Information on severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) may provide insights into the effects of COVID-19's during pregnancy. Even though SARS and MERS have been associated with miscarriage, intrauterine death, fetal growth restriction and high case fatality rates, the clinical course of COVID-19 pneumonia in pregnant women has been reported to be similar to that in non-pregnant women. In addition, pregnant women do not appear to be at a higher risk of catching COVID-19 or suffering from more severe disease than other adults of similar age. Moreover, there is currently no evidence that the virus can be transmitted to the fetus during pregnancy or during childbirth. Babies and young children are also known to only experience mild forms of COVID-19. The aims of this systematic review were to summarize the possible symptoms, treatments, and pregnancy outcomes of women infected with COVID-19 during pregnancy.
Competing Interests: Competing Interests: The authors have declared that no competing interest exists.
(© The author(s).)

Informacja